Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells (Q47796641)

5 February 2018

title

Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells (English)

1 reference

5 February 2018

0 references

Masaharu Hatakeyama

1

1 reference

5 February 2018

Tadaatsu Imaizumi

2

1 reference

5 February 2018

Wakako Tamo

3

1 reference

5 February 2018

Koji Yamashita

4

1 reference

5 February 2018

Hidemi Yoshida

5

1 reference

5 February 2018

Ikuo Fukuda

6

1 reference

5 February 2018

Kei Satoh

7

1 reference

5 February 2018

publication date

1 February 2004

1 reference

5 February 2018

published in

Inflammation

1 reference

5 February 2018

volume

28

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

7-13

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1023/b:ifla.0000014706.49598.78

exact match

0 references

cites work

GMP-140 binding to neutrophils is inhibited by sulfated glycans

1 reference

12 December 2020

Human interleukin 4 is a glycosaminoglycan-binding protein

1 reference

12 December 2020

Inhibition of the enzymatic activity of the first component of complement (C1) by heparin

1 reference

12 December 2020

NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS.

1 reference

12 December 2020

Growth factors in the extracellular matrix

1 reference

12 December 2020

Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes

1 reference

12 December 2020

Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycans

1 reference

12 December 2020

The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules

1 reference

12 December 2020

Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity.

1 reference

12 December 2020

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

1 reference

12 December 2020

Proteoglycans: structures and interactions

1 reference

12 December 2020

Dextran sulfate inhibits IFN-gamma-induced Jak-Stat pathway in human vascular endothelial cells

1 reference

12 December 2020

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

1 reference

12 December 2020

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

1 reference

12 December 2020

Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells

1 reference

12 December 2020

The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation

1 reference

12 December 2020

Endothelial cells for studies of platelet-activating factor and arachidonate metabolites

1 reference

12 December 2020

Heparan sulfate: a piece of information

1 reference

12 December 2020

Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

1 reference

12 December 2020

A new class of membrane-bound chemokine with a CX3C motif

1 reference

12 December 2020

Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).

1 reference

12 December 2020

Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response

1 reference

12 December 2020

Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity

1 reference

12 December 2020

Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance

1 reference

12 December 2020

The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis

1 reference

12 December 2020

Role of interferon-gamma in immune cell regulation.

1 reference

12 December 2020

Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines

1 reference

12 December 2020

Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture

1 reference

12 December 2020

The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes.

1 reference

12 December 2020

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

1 reference

12 December 2020

Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha

1 reference

12 December 2020

Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-gamma.

1 reference

12 December 2020

The heparin-binding (fibroblast) growth factor family of proteins

1 reference

12 December 2020

Glycosaminoglycans alter the conformation of interferon-gamma

1 reference

12 December 2020

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

1 reference

12 December 2020

Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups

1 reference

12 December 2020

Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha--an autocrine regulation of angiogenesis and inflammatory reactions

1 reference

12 December 2020

10.1023/B:IFLA.0000014706.49598.78

Identifiers

DOI

1 reference

5 February 2018

Dimensions Publication ID

0 references

1 reference

5 February 2018